Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yingzhi Bi is active.

Publication


Featured researches published by Yingzhi Bi.


Bioorganic & Medicinal Chemistry Letters | 2001

The discovery of novel, potent and selective PDE5 inhibitors

Yingzhi Bi; Patrick Stoy; Leonard P. Adam; Bin He; John Krupinski; Diane E. Normandin; Ron Pongrac; Laurie Seliger; Andrew Watson; John E. Macor

The design and synthesis of a novel scaffold for potent and selective PDE5 inhibitors are described. Compound 3a was more potent (PDE5 IC50=0.31 nM) and selective (>10,000-fold vs PDE1 and 160-fold selective vs PDE6) PDE5 inhibitor than sildenafil.


Endocrinology | 2007

Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats

Jacek Ostrowski; Joyce E. Kuhns; John A. Lupisella; Mark C. Manfredi; Blake C. Beehler; Stanley R. Krystek; Yingzhi Bi; Chongqing Sun; Ramakrishna Seethala; Rajasree Golla; Paul G. Sleph; Aberra Fura; Yongmi An; Kevin Kish; John S. Sack; Kasim A. Mookhtiar; Gary J. Grover; Lawrence G. Hamann


Archive | 2003

Bicyclic modulators of androgen receptor function

Chongqing Sun; Lawrence G. Hamann; David J. Augeri; Yingzhi Bi; Jeffrey A. Robl; Yanting Huang; Tammy C. Wang; Alexandra Holubec; Ligaya M. Simpkins; James C. Sutton; James J. Li


Archive | 2001

Quinoline Inhibitors of cGMP Phosphodiesterase

Yingzhi Bi; Guixue Yu; David P. Rotella; John E. Macor


Archive | 2004

Monocyclic N-aryl hydantoin modulators of androgen receptor function

Yingzhi Bi; Lawrence G. Hamann; Mark C. Manfredi; Ligaya M. Simpkins


Archive | 2005

Sulfonylpyrrolidine modulators of androgen receptor function and method

Lawrence G. Hamann; Yingzhi Bi; Mark C. Manfredi; Alexandra A. Nirschl; James C. Sutton


Bioorganic & Medicinal Chemistry Letters | 2004

Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction

Yingzhi Bi; Patrick Stoy; Leonard P. Adam; Bin He; John Krupinski; Diane E. Normandin; Ron Pongrac; Laurie Seliger; Andrew Watson; John E. Macor


Bioorganic & Medicinal Chemistry Letters | 2007

Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.

Lawrence G. Hamann; Mark C. Manfredi; Chongqing Sun; Stanley R. Krystek; Yanting Huang; Yingzhi Bi; David J. Augeri; Tammy C. Wang; Yan Zou; David A. Betebenner; Aberra Fura; Ramakrishna Seethala; Rajasree Golla; Joyce E. Kuhns; John A. Lupisella; Celia D'Arienzo; Laura Custer; Jennifer Price; James M. Johnson; Scott A. Biller; Robert Zahler; Jacek Ostrowski


Bioorganic & Medicinal Chemistry Letters | 2007

Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.

Mark C. Manfredi; Yingzhi Bi; Alexandra A. Nirschl; James C. Sutton; Ramakrishna Seethala; Rajasree Golla; Blake C. Beehler; Paul G. Sleph; Gary J. Grover; Jacek Ostrowski; Lawrence G. Hamann


Archive | 2010

Modulators of g protein-coupled receptor 88

Carolyn Diane Dzierba; Richard A. Hartz; Yingzhi Bi; Vijay T. Ahuja; Joanne J. Bronson; Kenneth Carson; Giovanni Cianchetta; Michael Green; David Kimball; S. Roy Kimura; Soojin Kwon; John E. Macor; Yulian Zhang; Greg Zipp

Collaboration


Dive into the Yingzhi Bi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yulian Zhang

Lexicon Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Godwin Kumi

Lexicon Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan Main

Lexicon Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge